Serotonin Type 6 and 7 Receptors as a Novel Therapeutic Target for the Treatment of Schizophrenia
Etsay Weldekidan Tsegay,1 Desalegn Getnet Demise,1 Nigus Alemu Hailu,2 Zenawi Hagos Gufue3 1Department of Pharmacy, College of Medicine and Health Sciences, Adigrat University, Adigrat, Tigray, Ethiopia; 2Department of Biomedical Science, College of Medicine and Health Sciences, Adigrat University,...
Guardado en:
Autores principales: | Tsegay EW, Demise DG, Hailu NA, Gufue ZH |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a89891def74448d187250b78096cc001 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy of serotonin receptor agonists in the treatment of functional dyspepsia: a meta-analysis
por: Man Jin, et al.
Publicado: (2018) -
The Structural Determinants for α<sub>1</sub>-Adrenergic/Serotonin Receptors Activity among Phenylpiperazine-Hydantoin Derivatives
por: Katarzyna Kucwaj-Brysz, et al.
Publicado: (2021) -
The serotonergic system and cognitive function
por: Švob Štrac Dubravka, et al.
Publicado: (2016) -
Beneficial effects of trimetazidine on expression of serotonin and serotonin transporter in rats with myocardial infarction and depression
por: Liu MY, et al.
Publicado: (2018) -
Liberation of Serotonin Is Not Unaffected by Acetylcholine in Rat Hippocampus
por: Jae Heon Kim, et al.
Publicado: (2021)